Theodore Gourdin to Prostatic Neoplasms, Castration-Resistant
This is a "connection" page, showing publications Theodore Gourdin has written about Prostatic Neoplasms, Castration-Resistant.
Connection Strength
3.174
-
Recent advances in the treatment of advanced prostate cancer: maximizing existing therapies while searching for novel solutions. Curr Opin Oncol. 2022 05 01; 34(3):228-233.
Score: 0.753
-
Highlighting recent treatment advances in metastatic prostate cancer: expanding the treatment arsenal. Curr Opin Oncol. 2021 05 01; 33(3):252-256.
Score: 0.703
-
Recent progress in treating advanced prostate cancer. Curr Opin Oncol. 2020 05; 32(3):210-215.
Score: 0.656
-
Recent advances in the management of metastatic prostate cancer: optimizing use of existing therapies, while searching for novel interventions. Curr Opin Oncol. 2018 05; 30(3):159-164.
Score: 0.571
-
Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer. Prostate. 2022 09; 82(13):1264-1272.
Score: 0.190
-
Optimization of therapies for men with advanced prostate cancer: a review of recent developments with a look toward the future. Curr Opin Oncol. 2019 05; 31(3):188-193.
Score: 0.153
-
Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer. Cancer. 2019 05 01; 125(9):1459-1469.
Score: 0.150